Roth Capital Downgrades Ohr Pharmaceutical (OHRP) to Neutral Following MAKO Results
Tweet Send to a Friend
Roth Capital downgraded Ohr Pharmaceutical (NASDAQ: OHRP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
